← Open Payments lookup

MARCEL FILART: Open Payments

NPI 1396775474 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$882 in 32 payments from 9 companies in 2025. Trend: 2023 $389 · 2024 $331 · 2025 $882

Food & beverage: $790Education: $91
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$415
Amgen Inc.7$190
Lilly USA, LLC2$155
Otsuka America Pharmaceutical, Inc.1$25
Alkermes, Inc.1$23
Abbott Laboratories1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Bayer Healthcare Pharmaceuticals Inc.1$17
Gilead Sciences, Inc.1$15

Products named: UZEDY, KRYSTEXXA, ZEPBOUND, AUSTEDO XR, MOUNJARO, OTEZLA, REXULTI, ARISTADA.

Industry payments across CA — which companies pay providers there.